| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/11/1993 | US5210076 Methods of treating Parkinson's disease using melanin |
| 05/11/1993 | US5210017 Ligand-mediated immunofunctional hormone binding protein assay method |
| 05/11/1993 | US5209933 A dihydropyridine compound |
| 05/11/1993 | US5209927 Ophthalmic solution |
| 05/11/1993 | US5209926 Aminosteroids for ophthalmic use |
| 05/11/1993 | US5209922 Undecylenic acid salt of quaternized copolymer of vinylpyrrolidone and aminoalkylacrylamide |
| 05/11/1993 | US5209920 Arthritis, administering a stimulant for the hypothalamic-pituitary adrenal axis and measuring hormone level |
| 05/11/1993 | CA1317598C 3(2h)-pyridazinone derivatives, pharmaceutical compositions containing them and process for preparing same |
| 05/11/1993 | CA1317597C 3,6-dihydro-1,5(2h)-pyrimidinecarboxylic acid esters |
| 05/11/1993 | CA1317595C Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as an active substance |
| 05/11/1993 | CA1317594C Aminomethyloxooxazolidinyl ethenylbenzene derivatives useful as antibacterial agents |
| 05/11/1993 | CA1317593C Method of ameliorating epileptic seizures |
| 05/11/1993 | CA1317590C 2-substituted-e-fused-¬1,2,4|triazolo¬1,5- c|pyrimidines, pharmaceutical compositions, and uses thereof |
| 05/11/1993 | CA1317589C Modified lipopolysaccharides and process of preparation |
| 05/11/1993 | CA1317587C Esters |
| 05/11/1993 | CA1317550C Dosage form for treating cardiovascular diseases |
| 05/11/1993 | CA1317549C Analgesic containing a pyrimidine derivative |
| 05/11/1993 | CA1317548C Freeze-dried pharmaceutical preparations for parenteral use |
| 05/11/1993 | CA1317546C Pharmaceutical preparations containing mixtures of hydroxy derivatives of vitamin d |
| 05/11/1993 | CA1317545C Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
| 05/11/1993 | CA1317542C Glutaraldehyde-based sterilising composition of antibacterial and antimycotic activity, in an aqueous vehicle |
| 05/10/1993 | CA2082446A1 Alkoxylated phenyl and coumarin derivatives useful in the treatment of viral infections |
| 05/09/1993 | WO1993009239A1 Adeno-associated virus-2 basal vectors |
| 05/09/1993 | CA2082297A1 Synthesis and elucidation of pyrimido [4, 5-g] quinazoline derivatives |
| 05/09/1993 | CA2082037A1 1-alkyl-2-acyl-1,2-disulfonylhydrazines |
| 05/08/1993 | CA2082216A1 Polycyclic conjugates |
| 05/07/1993 | CA2082144A1 Squalene synthetase inhibitory composition and use thereof |
| 05/07/1993 | CA2082023A1 Diethylenetriamine derivatives and their use for diagnostic and therapeutic purposes |
| 05/06/1993 | DE4234933A1 New phthalazine derivs. |
| 05/06/1993 | DE4210711A1 Transdermale therapeutische systeme mit kristallisationsinhibitoren Transdermal therapeutic systems with crystallization inhibitors |
| 05/06/1993 | CA2082076A1 Pyridine-2,4 and -2,5-dicarboxamides and their derivatives, process for their preparation, and their use |
| 05/05/1993 | EP0540506A2 Organosiloxane-containing polysaccharides |
| 05/05/1993 | EP0540472A1 Butyric acid derivatives, process for their preparation and their use as pesticides |
| 05/05/1993 | EP0540462A1 L-Glutamine or a peptide rich in L-glutamine for the manufacture of an oral formulation for the treatment of a fall in blood L-glutamine levels |
| 05/05/1993 | EP0540421A1 Indigestible dextrin |
| 05/05/1993 | EP0540400A1 Quinoline derivatives, useful as angiotensin II antagonists |
| 05/05/1993 | EP0540356A2 Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof |
| 05/05/1993 | EP0540334A1 Fibrinogen receptor antagonists |
| 05/05/1993 | EP0540318A1 2-Heterocyclicethylamine derivatives and their use as pharmaceuticals |
| 05/05/1993 | EP0540209A1 Imidazole derivatives and pharmaceutical compositions containing the same |
| 05/05/1993 | EP0540165A1 Alkanoic acid derivatives |
| 05/05/1993 | EP0540143A2 Compounds and methods for inhibition of HIV and related viruses |
| 05/05/1993 | EP0540099A1 Water soluble camptothecin derivatives |
| 05/05/1993 | EP0540051A1 Aromatic amidine derivatives and salts thereof |
| 05/05/1993 | EP0539977A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and their use as analgesic agents and prostaglandin antagonists |
| 05/05/1993 | EP0539976A1 Ethynyl-alanine-amino-diol compounds for treatment of hypertension |
| 05/05/1993 | EP0539960A2 Hematoporphyrin derivatives complex salts and their use in the detection and treatment of neoplasms |
| 05/05/1993 | EP0539938A1 Tri-substituted tetrahydrofuran antifungals |
| 05/05/1993 | EP0539920A1 Medicament for the treatment of AIDS |
| 05/05/1993 | EP0539886A1 Use of aqueous carbohydrate solution as irrigation fluid for arthroscopy |
| 05/05/1993 | EP0539848A1 N-(mercaptoacyl)amino acids, methods of their preparation and therapeutic use, and pharmaceutical compositions containing them |
| 05/05/1993 | EP0539806A1 Thiadiazinones and medicines containing them, having in particular a positive inotropic and vasodilating activity |
| 05/05/1993 | EP0539805A1 Phthalazines substituted on position 1 by an ether or a thioether group and process for their preparation |
| 05/05/1993 | EP0539803A1 Triazospirodecanone-methyl-chromans for the treatment of central nervous system illnesses |
| 05/05/1993 | EP0539751A1 Biodegradable polymer composition |
| 05/05/1993 | EP0539713A1 Substituted imidazolylpropene acid derivatives as angiotensin II inhibitors |
| 05/05/1993 | EP0539627A1 A process for the purification of commercial carrageenins |
| 05/05/1993 | EP0539591A1 Benzodiazepine derivatives |
| 05/05/1993 | EP0539587A1 Antiretroviral agent |
| 05/05/1993 | EP0539527A1 Analogs of carbonic anhydrase inhibitors and their use as topical iop inhibitors |
| 05/05/1993 | EP0539525A1 Vitaletheine and use in cell culture and therapy |
| 05/05/1993 | EP0539509A1 4-alkylimidazole derivatives. |
| 05/05/1993 | EP0539506A1 Method for treating viral infections using oxidized lipoproteins |
| 05/05/1993 | EP0539487A1 Antiviral phosphono-alken derivatives of purines |
| 05/05/1993 | EP0539465A1 Use of 20(r)-22-oxa-vitamin d analogues for the treatment of skin ageing. |
| 05/05/1993 | EP0539457A1 Compositions based on active principles of hydrophobic medicaments solubilizable in an aqueous solvent |
| 05/05/1993 | EP0539451A1 Vinylsulphonyl pristinamycin and preparation thereof. |
| 05/05/1993 | EP0539442A1 Enzyme inactivators |
| 05/05/1993 | EP0539421A1 Novel oxazolyl derivatives |
| 05/05/1993 | EP0539420A1 Novel substituted thiazolyl and substituted pyridinyl derivatives |
| 05/05/1993 | EP0539418A1 Imidazopyridine paf antagonists |
| 05/05/1993 | EP0539380A1 Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses |
| 05/05/1993 | EP0539372A1 Therapeutic agents |
| 05/05/1993 | EP0533818A4 Process for activating reproduction of seasonal breeding animals by administering l-dihydroxyphenylalanine (l-dopa) |
| 05/05/1993 | CN1071668A Anti-endotoxin compounds |
| 05/05/1993 | CN1071667A Phenothiazine quaternary ammonium derivative and process for preparing their composition |
| 05/05/1993 | CN1071666A Tetrahydroberberine type quaternary ammonium componnd and preparing process |
| 05/05/1993 | CN1071665A Oxazolidone derivative |
| 05/05/1993 | CN1071577A Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 05/05/1993 | CN1071576A Injectable veterinary composition being free from toxic side effects and process for the preparation thereof |
| 05/05/1993 | CN1071575A Preparing method for coating agent of complex triamcinolone acetonide acetate |
| 05/05/1993 | CN1020452C Process for preparing 10-dihydro-10 deoxo-11-azaerythronolide a derivatives and their biologicalproperties |
| 05/05/1993 | CN1020404C Preparation of corn plaster |
| 05/05/1993 | CA2081808A1 Combination of calcium antagonists with cholinesterase inhibitors |
| 05/04/1993 | US5208324 Paramagnetic compounds |
| 05/04/1993 | US5208263 Anti-androgen compounds |
| 05/04/1993 | US5208262 Administering 4-hydroxythiophenol derivatives |
| 05/04/1993 | US5208260 Vinyl Glycine derivatives for memory and learning enhancement or treatment of a cognitive disorder |
| 05/04/1993 | US5208259 Diaryl ether hetrocycles |
| 05/04/1993 | US5208257 Topical antimicrobial pharmaceutical compositions and methods |
| 05/04/1993 | US5208256 Treatment of ocular hypertension with a synergistic combination for ocular administration |
| 05/04/1993 | US5208255 Thioester enantiomeric compounds and their therapeutic uses |
| 05/04/1993 | US5208254 Liver Disorder Treatment |
| 05/04/1993 | US5208253 Antiinflammatory agents |
| 05/04/1993 | US5208251 Compounds for antiinflammatory agents, antiallergens, antiarthritic, antiulcer agents |
| 05/04/1993 | US5208250 Known and selected novel arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and anti-inflammatory agents |
| 05/04/1993 | US5208249 Method for stimulating intracellular synthesis of glutathione using esters of L-2-oxothiazolidine-4-carboxylate |
| 05/04/1993 | US5208247 Pyridinium compounds which are useful as antagonists of platelet activating factor |
| 05/04/1993 | US5208246 Tetralones with pharmacological activity |
| 05/04/1993 | US5208245 Hypotensive agents |